GDSI statin use significantly reduces recurrent atherosclerotic cardiovascular disease events and mortality compared to less intensive regimens or no statins.
Does GDSI reduce recurrent ASCVD events and mortality in patients with coronary artery intervention compared to less intensive regimens or no statins?
Intensive statin therapy reduces recurrent ASCVD events and mortality more effectively than less intensive regimens or no statins in patients following coronary artery intervention.
Tasa de eventos absoluta: 0% vs 0%
GDSI reduces recurrent ASCVD events and mortality more effectively than less intensive regimens or no statins. Optimizing statin use and LDL cholesterol monitoring could improve ASCVD management and outcomes.
Ahmed et al. (Tue,) reported a other. GDSI statin use significantly reduces recurrent atherosclerotic cardiovascular disease events and mortality compared to less intensive regimens or no statins.